# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Walgreens agrees to pay $106.8 million to settle claims of false billing to federal health care programs. The settlement addres...
Cantor Fitzgerald analyst Sarah James reiterates CVS Health (NYSE:CVS) with a Neutral and maintains $62 price target.
PayPal will become an additional credit and debit card processor for Shopify Payments through its PayPal Complete Payments solu...
UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amge...
CVS Health Corporation (NYSE: CVS) shares are seeing a The sell-off comes in the wake of the recent Trump-Harris debate, which ...
Baltimore secures an $80 million settlement with Teva Pharmaceuticals in its opioid crisis litigation. Funds will be allocated ...
Cantor Fitzgerald analyst Sarah James reiterates CVS Health (NYSE:CVS) with a Neutral and maintains $62 price target.